Geron
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 2 weeks.
- Its last 4 Sell calls were followed by roughly flat moves (-0%) three months out.
- Recent price momentum is -32.4% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 10.4% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 5 of 6 factors. Missing data is not a zero score.
The radar needs all six factors. Available grades are shown below.
Valuation C
How expensive the stock is versus earnings, sales and its own 5-year history.
| Forward P/E | 20.5x | Better than 35% |
| Price / Sales | 2.9x | Better than 44% |
Growth N/A
How fast revenue, profit and free cash flow are compounding.
Not enough data to grade this factor.
Profitability C-
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 97.4% | Better than 99% |
| Operating margin | -28.0% | Better than 11% |
| Net margin | -45.4% | Better than 9% |
| Return on equity | -33.0% | Better than 12% |
| Return on invested capital | -18.4% | Better than 14% |
Momentum D
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -42.8% | Better than 9% |
| 6-month return | -32.0% | Better than 17% |
| 12-month return (ex latest month) | 0.0% | Better than 34% |
| Distance below 52-week high | 56.7% | Better than 13% |
Financial Health B-
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 4.7x | Better than 84% |
| Debt to assets | 21.4% | Better than 54% |
| Interest coverage | -1.6x | Better than 21% |
Analyst View A-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 75.0% | Better than 51% |
| Upside to average target | 339.9% | Better than 98% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 0.91
- Open
- 0.89
- Day range
- 0.86 - 0.93
- Avg price
- 0.90
- Volume
- 13.83M
- Turnover
- 12.39M
- Turnover ratei
- 2.50%
- Volume ratioi
- 0.82
- Amplitudei
- 6.96%
- 52-week rangei
- 0.84 - 2.01
Valuation
- P/Ei
- -6.70
- P/E (TTM)i
- -10.88
- P/Bi
- 2.47
- EPSi
- -0.13
- Book value / shi
- 0.35
- Net profit
- -83.75M
- Net assets
- 226.77M
Share structure
- Market cap
- 560.94M
- Float capi
- 482.46M
- Shares out
- 644.24M
- Float sharesi
- 554.11M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- --
56.7% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-14.80M net over the window
Short interest
- Shares short
- 66.95M
- % of floati
- 10.42%
- Days to coveri
- 3.92
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Geron (GERN)?
Geron last traded at 0.87. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Geron's market cap?
About 560.94M.
What is the P/E ratio of Geron?
The trailing twelve-month P/E is -10.88. The Valuation tab shows it against the stock's own five-year range.
Does Geron pay a dividend?
Geron does not currently pay a regular dividend.
Is Geron a buy according to analysts?
The consensus of 4 analysts is a Buy rating, with an average 12-month price target of 3.83, which implies 339.9% upside from the current price. This is not investment advice.
What is Geron's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Geron a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Geron discussion 0 comments